White Paper Addresses FDA Approval Challenges Facing Combination Product Manufacturers
Posted on: Monday, 1 December 2008, 09:20 CST
"Given the convergence of technologies, combination product manufacturers - often either medical device or pharmaceutical companies 'crossing over to the new market' - must ensure their products meet cGMP practices as well as pass muster with the Food and Drug Administration (FDA), the International Organization for Standardization (ISO), and The United States Pharmacopeia (USP)," said
"The combination products market is rapidly moving forward with a new direction and emphasis regarding product safety and FDA requirements," said Richter. "The process, already complex, is likely to become even more so," he warned.
In fiscal 2007, the FDA received 333 original applications for combination products, a 42 percent increase over 2006. The FDA itself reports that combination product submissions "raise challenging regulatory, policy, and review management issues... [that] can impact the regulatory processes of all aspects of the product life cycle."
In the free white paper, "Combination Products: Navigating Two FDA Quality Systems," Richter provides a helpful overview of the challenges facing combination product manufacturers. Download the white paper at www.microtestlabs.com/combinationpaper.
"For manufacturers, the convergence of devices and drugs or biologics brings a host of new FDA testing guidelines, practices, and regulations unique to the development and production of combination products - and generally outside their original core competence in achieving regulatory approvals as either a medical device or pharmaceutical manufacturer," he said.
In the white paper, Richter discusses: Defining the Convergence, FDA Responsibility, QC Drug Release Criteria, Biologics, New Developments in FDA Thinking, and Future Considerations.
According to the FDA, some estimate the total global value of the drug-device combination products market will grow to
Download the free white paper at: www.microtestlabs.com/combinationpaper. For more information, visit Microtest on the Web at www.microtestlabs.com, or call toll-free: 1-800-631-1680.
About Microtest
Microtest is a leader in testing services and contract manufacturing for the medical device, pharmaceutical, and biotechnology industries. Based in
Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
SOURCE Microtest
Source: PR Newswire
Related Articles
- CBI Announces the Agenda for its Forum on FDA's Structured Product Labeling (SPL R4)
- Particle Sciences Further Expands Combination Product Development Capabilities
- Japanese Product Innovation Series Market Report: Review of New Food and Beverage Products Out Now
- Premier Names VP of Integrated Product Management and Marketing To Lead Development of New Solutions for Hospitals
- Andrx Announces Filing of NDA By Takeda for ACTOS and Extended-Release Metformin Combination Product
- TyRx Pharma's Anesthetic Coated Surgical Mesh Combination Product Assigned to 'Device' Center at FDA
- Angiotech Announces Vascular Wrap(TM)/Lifespan(R) Vascular Graft Combination Product Receives Designation of "Device" for U.S. Pivotal Study
- TyRx Pharma, Inc. Joins the Combination Products Coalition
- Pharmaceutical Companies Turn Toward Fixed-Dose Combination Products
- Cornerstone BioPharma, Inc. Acquires EXTENDRYL Family of Products From FLEMING & COMPANY, Pharmaceuticals
 |
 |
User Comments (0)
RSS Feeds